Biotech focused on organ transplant technologies

BREONICS is a biomedical research and discovery company that is commercializing a new organ regeneration platform called the Exsanguinous Metabolic Support ("EMS") system. The mission of BREONICS is to become a world leader in the development of technologies that change the world of organ transplantation. The company plans to accomplish this by using technology to expand the donor pool, reduce tissue rejection and enable tissue regeneration.